- Home
- IMOS vs OPK Comparison
IMOS vs OPK Comparison
Compare IMOS & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMOS
- OPK
- Stock Information
- Founded
- IMOS 1997
- OPK 2007
- Country
- IMOS Taiwan
- OPK United States
- Employees
- IMOS N/A
- OPK N/A
- Industry
- IMOS Semiconductors
- OPK Biotechnology: Pharmaceutical Preparations
- Sector
- IMOS Technology
- OPK Health Care
- Exchange
- IMOS Nasdaq
- OPK Nasdaq
- Market Cap
- IMOS 534.3M
- OPK 1.0B
- IPO Year
- IMOS N/A
- OPK 1995
- Fundamental
- Price
- IMOS $19.36
- OPK $1.51
- Analyst Decision
- IMOS
- OPK Buy
- Analyst Count
- IMOS 0
- OPK 4
- Target Price
- IMOS N/A
- OPK $2.75
- AVG Volume (30 Days)
- IMOS 16.6K
- OPK 2.1M
- Earning Date
- IMOS 11-04-2025
- OPK 11-06-2025
- Dividend Yield
- IMOS 3.36%
- OPK N/A
- EPS Growth
- IMOS N/A
- OPK N/A
- EPS
- IMOS 0.01
- OPK N/A
- Revenue
- IMOS $777,452,000.00
- OPK $664,029,000.00
- Revenue This Year
- IMOS $3.76
- OPK N/A
- Revenue Next Year
- IMOS $5.93
- OPK $0.84
- P/E Ratio
- IMOS $115.81
- OPK N/A
- Revenue Growth
- IMOS 0.89
- OPK N/A
- 52 Week Low
- IMOS $12.78
- OPK $1.11
- 52 Week High
- IMOS $23.85
- OPK $2.04
- Technical
- Relative Strength Index (RSI)
- IMOS 71.64
- OPK 66.28
- Support Level
- IMOS $18.30
- OPK $1.34
- Resistance Level
- IMOS $18.66
- OPK $1.44
- Average True Range (ATR)
- IMOS 0.36
- OPK 0.05
- MACD
- IMOS 0.31
- OPK 0.00
- Stochastic Oscillator
- IMOS 100.00
- OPK 97.06
About IMOS ChipMOS TECHNOLOGIES INC.
ChipMOS TECHNOLOGIES Inc is engaged in the research, development, manufacturing, and sale of high-integration and high-precision integrated circuits and related assembly and testing services. The company's segments include Testing, Assembly, Testing, and Assembly for LCD, OLED, and other Display Panel Driver Semiconductors (LCDD), Bumping, and others. It derives a majority of its revenue from Taiwan followed by Japan, the People's Republic of China, Singapore, and others.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.